""The facts compel the federal government to recognize that marijuana can be legitimate in terms of medical applications when carefully administered," Trump said. He added that such applications include substituting marijuana for "addictive" and "potentially lethal" opiates. The Centers for Medicare & Medicaid Services (CMS) did not immediately respond to Axios' request for comment. Here's what we know about a pilot program for Medicare to cover cannabis: What the order means for seniors, Medicare"
"The fine print: Medicare will specifically only cover cannabidiol products, or CBD. Coverage will start "as early as April of next year at no charge, if their doctors recommend them," CMS administrator Mehmet Oz said at the signing. The Department of Health & Human Services (HHS) has recently indicated an openness to loosening cannabis product restrictions. TheCMS published a proposed rule change in the Federal Register last month that would authorize insurance coverage for CBD products under Medicare Advantage programs."
In 2023, 7% of adults aged 65 or older reported past-month marijuana use, up from 4.8% in 2021 and 5.2% in 2022, a nearly 46% increase in two years. A presidential executive order reclassified marijuana as a Schedule III drug under the DEA and authorized a Medicare pilot program. The reclassification places cannabis in a category with products like Tylenol with codeine rather than Schedule I substances. Medicare will specifically cover cannabidiol (CBD) products if recommended by doctors, with coverage possibly starting as early as April. HHS signaled openness to loosening cannabis restrictions and proposed CBD coverage under Medicare Advantage.
Read at Axios
Unable to calculate read time
Collection
[
|
...
]